Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

755
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
755
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

685
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
685
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

190
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
190
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

196
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
196
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

210
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
210

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hughes-Stovin syndrome (HSS) preliminary diagnostic criteria: a paradigm shift in managing pulmonary vasculitis in HSS and Behçet's disease (BD). On behalf of the HSS International Study Group (HSSISG) : Reply on Tahir Saygın Öğüt and Veli Yazısız "Comments on the proposed diagnostic criteria for Hughes-Stovin syndrome: the role of Behçet syndrome" (CLRH-D-26-01350).

Clinical rheumatology·2026
Same author

Ambulatory hypertension and left ventricular hypertrophy in pediatric chronic kidney disease: a systematic review and meta-analysis.

European journal of pediatrics·2026
Same author

Adaptation and evaluation of PRO-Kid (patient-reported outcome measure for the assessment of symptoms burden in pediatric chronic kidney disease) for children aged 2-7 years.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Improving pediatric post-acute kidney injury care: considerations for the clinician.

Renal failure·2026
Same author

Evaluating construct validity of the PRO-Kid life participation tool for children living with chronic kidney disease.

Pediatric nephrology (Berlin, Germany)·2026
Same author

Efficacy and Safety of Rituximab Therapy to Sustain Remission in Young Children With Childhood Nephrotic Syndrome.

Kidney international reports·2026

Related Experiment Video

Updated: Dec 5, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

397

Malignancies after pediatric solid organ transplantation.

Cal Robinson1,2, Rahul Chanchlani3,4,5, Abhijat Kitchlu6

  • 1Division of Paediatric Nephrology, Department of Paediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada.

Pediatric Nephrology (Berlin, Germany)
|October 15, 2020
PubMed
Summary
This summary is machine-generated.

Pediatric solid organ transplant recipients (SOTRs) face increased cancer risks, including post-transplantation lymphoproliferative disorders and various cancers. Individualized screening and prevention are crucial due to unique risk factors.

Keywords:
CancerMalignancyPediatricPost-transplantation lymphoproliferative disorderSolid organ transplant

More Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.1K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.6K

Related Experiment Videos

Last Updated: Dec 5, 2025

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
08:31

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia

Published on: October 17, 2025

397
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

1.1K
Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
06:08

Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model

Published on: February 10, 2023

1.6K

Area of Science:

  • Oncology
  • Transplantation Medicine
  • Pediatric Health

Background:

  • Improved life expectancy in pediatric solid organ transplant recipients (SOTRs) leads to increased risks of post-transplantation malignancies.
  • SOTRs have elevated risks for post-transplantation lymphoproliferative disorders (PTLDs) and both skin and solid cancers.
  • Cancer incidence reaches 26-41% by 30 years post-transplantation, with PTLDs occurring early and other cancers in young adulthood.

Purpose of the Study:

  • To highlight the increased risk of malignancy in pediatric SOTRs.
  • To discuss the distinct risk factors and timing for different cancer types post-transplantation.
  • To emphasize the need for tailored cancer screening and prevention strategies in this population.

Main Methods:

  • Review of existing literature on post-transplant malignancies in pediatric SOTRs.
  • Analysis of risk factors including immunosuppression, infections, organ type, and underlying disease.
  • Evaluation of current treatment and prevention strategies.

Main Results:

  • PTLDs and skin/solid cancers are significant long-term risks for pediatric SOTRs.
  • Risk factors are multifactorial, influenced by immunosuppression intensity, infections, and transplant specifics.
  • Cancer treatment requires balancing efficacy with risks of rejection and allograft loss.

Conclusions:

  • Current cancer screening guidelines for the general population are not validated for pediatric SOTRs.
  • An individualized approach to cancer screening is essential, considering unique patient risk profiles.
  • Prevention strategies like lifestyle counseling and vaccinations are vital components of care.